Other substances

Cytarabine

A cytidine analogue.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
5
 AI-suggested references
0
 Clinical trials

General information

Cytarabine on DrugBank
Cytarabine on PubChem

Marketed as

ARA-C; CYTARABINE; CYTOSAR; DEPOCYT; DEPOCYTE

 

Structure image - Cytarabine

C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis
Small molecule In silico Screening 		in silico (protein-protein interaction network analysis) 2.31

Computationally predicted to be efficacious in COVID-19 treatment based on protein-protein interaction network analysis.

 Mar/12/2021

AI-suggested references

Link Publication date
Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment.
May/29/2020
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
Jan/19/2022
Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19
May/20/2021
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study.
Apr/28/2021
Marine Sponge is a Promising Natural Source of Anti-SARS-CoV-2 Scaffold.
May/13/2021
Export (.csv)